There are three medications with FDA approval for nicotine dependence: Nicotine replacement therapies, bupropion, and varenicline. Varenicline (Chantix) is arguably the most effective, but cost and concerns about neuropsychiatric side effects have limited its use, and a recent recall of the product temporarily stopped it entirely.
Read More
Race and identity are hot topics, even for White people, so psychiatrists need to find a better way to talk about it. The pandemic brought the dynamics of oppression and inequality to the forefront in medicine. Racism is not just happening in the news, the protests, and the Black Lives Matter movement.
Read More
Tricyclics have been used in psychiatry since the 1950s, when imipramine was introduced as the first mass-marketed antidepressant. Fluoxetine and the other SSRIs largely supplanted the tricyclics in the 1990s, but these medications still have their uses.
Read More
The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME Credit.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
